Deep sequencing identifies hepatitis B virus core protein signatures in chronic hepatitis B patients

Meike H. van der Ree, Louis Jansen, Matthijs R. A. Welkers, Hendrik W. Reesink, K. Anton Feenstra, Neeltje A. Kootstra

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

BACKGROUND: We aimed to identify HBc amino acid differences between subgroups of chronic hepatitis B (CHB) patients.

METHODS: Deep sequencing of HBc was performed in samples of 89 CHB patients (42 HBeAg positive, 47 HBeAg negative). Amino acid types were compared using Sequence Harmony to identify subgroup specific sites between HBeAg-positive and -negative patients, and between patients with combined response and non-response to peginterferon/adefovir combination therapy.

RESULTS: We identified 54 positions in HBc where the frequency of appearing amino acids was significantly different between HBeAg-positive and -negative patients. In HBeAg negative patients, 22 positions in HBc were identified which differed between patients with treatment response and those with non-response. The fraction non-consensus sequence on selected positions was significantly higher in HBeAg-negative patients, and was negatively correlated with HBV DNA and HBsAg levels.

CONCLUSIONS: Sequence Harmony identified a number of amino acid changes associated with HBeAg-status and response to peginterferon/adefovir combination therapy.

Original languageEnglish
Pages (from-to)213-225
Number of pages13
JournalAntiviral research
Volume158
Early online date16 Aug 2018
DOIs
Publication statusPublished - Oct 2018

Fingerprint

Viral Core Proteins
High-Throughput Nucleotide Sequencing
Chronic Hepatitis B
Hepatitis B e Antigens
Hepatitis B virus
Amino Acids
Hepatitis B Surface Antigens
Therapeutics
DNA

Keywords

  • Chronic hepatitis B
  • Deep sequencing
  • HBeAg status
  • Hepatitis B virus core protein
  • Treatment response

Cite this

van der Ree, Meike H. ; Jansen, Louis ; Welkers, Matthijs R. A. ; Reesink, Hendrik W. ; Feenstra, K. Anton ; Kootstra, Neeltje A. / Deep sequencing identifies hepatitis B virus core protein signatures in chronic hepatitis B patients. In: Antiviral research. 2018 ; Vol. 158. pp. 213-225.
@article{7d03b1c269db45779be07519aa2f155c,
title = "Deep sequencing identifies hepatitis B virus core protein signatures in chronic hepatitis B patients",
abstract = "BACKGROUND: We aimed to identify HBc amino acid differences between subgroups of chronic hepatitis B (CHB) patients.METHODS: Deep sequencing of HBc was performed in samples of 89 CHB patients (42 HBeAg positive, 47 HBeAg negative). Amino acid types were compared using Sequence Harmony to identify subgroup specific sites between HBeAg-positive and -negative patients, and between patients with combined response and non-response to peginterferon/adefovir combination therapy.RESULTS: We identified 54 positions in HBc where the frequency of appearing amino acids was significantly different between HBeAg-positive and -negative patients. In HBeAg negative patients, 22 positions in HBc were identified which differed between patients with treatment response and those with non-response. The fraction non-consensus sequence on selected positions was significantly higher in HBeAg-negative patients, and was negatively correlated with HBV DNA and HBsAg levels.CONCLUSIONS: Sequence Harmony identified a number of amino acid changes associated with HBeAg-status and response to peginterferon/adefovir combination therapy.",
keywords = "Chronic hepatitis B, Deep sequencing, HBeAg status, Hepatitis B virus core protein, Treatment response",
author = "{van der Ree}, {Meike H.} and Louis Jansen and Welkers, {Matthijs R. A.} and Reesink, {Hendrik W.} and Feenstra, {K. Anton} and Kootstra, {Neeltje A.}",
note = "Copyright {\circledC} 2018. Published by Elsevier B.V.",
year = "2018",
month = "10",
doi = "10.1016/j.antiviral.2018.08.009",
language = "English",
volume = "158",
pages = "213--225",
journal = "Antiviral research",
issn = "0166-3542",
publisher = "Elsevier",

}

Deep sequencing identifies hepatitis B virus core protein signatures in chronic hepatitis B patients. / van der Ree, Meike H.; Jansen, Louis; Welkers, Matthijs R. A.; Reesink, Hendrik W.; Feenstra, K. Anton; Kootstra, Neeltje A.

In: Antiviral research, Vol. 158, 10.2018, p. 213-225.

Research output: Contribution to JournalArticleAcademicpeer-review

TY - JOUR

T1 - Deep sequencing identifies hepatitis B virus core protein signatures in chronic hepatitis B patients

AU - van der Ree, Meike H.

AU - Jansen, Louis

AU - Welkers, Matthijs R. A.

AU - Reesink, Hendrik W.

AU - Feenstra, K. Anton

AU - Kootstra, Neeltje A.

N1 - Copyright © 2018. Published by Elsevier B.V.

PY - 2018/10

Y1 - 2018/10

N2 - BACKGROUND: We aimed to identify HBc amino acid differences between subgroups of chronic hepatitis B (CHB) patients.METHODS: Deep sequencing of HBc was performed in samples of 89 CHB patients (42 HBeAg positive, 47 HBeAg negative). Amino acid types were compared using Sequence Harmony to identify subgroup specific sites between HBeAg-positive and -negative patients, and between patients with combined response and non-response to peginterferon/adefovir combination therapy.RESULTS: We identified 54 positions in HBc where the frequency of appearing amino acids was significantly different between HBeAg-positive and -negative patients. In HBeAg negative patients, 22 positions in HBc were identified which differed between patients with treatment response and those with non-response. The fraction non-consensus sequence on selected positions was significantly higher in HBeAg-negative patients, and was negatively correlated with HBV DNA and HBsAg levels.CONCLUSIONS: Sequence Harmony identified a number of amino acid changes associated with HBeAg-status and response to peginterferon/adefovir combination therapy.

AB - BACKGROUND: We aimed to identify HBc amino acid differences between subgroups of chronic hepatitis B (CHB) patients.METHODS: Deep sequencing of HBc was performed in samples of 89 CHB patients (42 HBeAg positive, 47 HBeAg negative). Amino acid types were compared using Sequence Harmony to identify subgroup specific sites between HBeAg-positive and -negative patients, and between patients with combined response and non-response to peginterferon/adefovir combination therapy.RESULTS: We identified 54 positions in HBc where the frequency of appearing amino acids was significantly different between HBeAg-positive and -negative patients. In HBeAg negative patients, 22 positions in HBc were identified which differed between patients with treatment response and those with non-response. The fraction non-consensus sequence on selected positions was significantly higher in HBeAg-negative patients, and was negatively correlated with HBV DNA and HBsAg levels.CONCLUSIONS: Sequence Harmony identified a number of amino acid changes associated with HBeAg-status and response to peginterferon/adefovir combination therapy.

KW - Chronic hepatitis B

KW - Deep sequencing

KW - HBeAg status

KW - Hepatitis B virus core protein

KW - Treatment response

UR - http://www.scopus.com/inward/record.url?scp=85052436093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052436093&partnerID=8YFLogxK

U2 - 10.1016/j.antiviral.2018.08.009

DO - 10.1016/j.antiviral.2018.08.009

M3 - Article

VL - 158

SP - 213

EP - 225

JO - Antiviral research

JF - Antiviral research

SN - 0166-3542

ER -